DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

1.19 0.03 (2.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $1.19 2.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.18
Previous Close $1.17
Daily Range $1.17 - $1.25
52-Week Range $1.02 - $2.43
Market Cap $81.7M
P/E Ratio -1.79
Dividend (Yield) $0.00 (0.0%)
Volume 1,479,730
Average Daily Volume 647,821
Current FY EPS -$0.61

Sector

Healthcare

Industry

Drugs

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

StemCells Starts Phase II Cervical Spinal Cord Injury Study - Analyst Blog

StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity

StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript

StemCells (STEM) Q2 2014 Results - Earnings Call Webcast

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Sto

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Stock Sale

Sector Update: Health Care

Why StemCells (STEM) Stock Is Down Today

Morning Market Losers

Stock Downgrades: Declare Your Independence From Regado Biosciences

Wall Street ratings agencies set the tone for today's stock market.

Why StemCells (STEM) Stock Is Gaining Today

See More STEM News...

STEM's Top Competitors

STEM $1.19 (2.15%)
Current stock: STEM
AMGN $144.09 (4.79%)
Current stock: AMGN
GILD $106.67 (4.36%)
Current stock: GILD
BIIB $326.77 (4.93%)
Current stock: BIIB